Pancreatic Cancer Research

ResearcherFreeman HospitalActive in the last 2 years

John A. G. Moir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3161-4713; OpenAlex author ID A5055652993, A5110378103. Sources: OpenAlex.

Their work

Papers
16 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2014: 2 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 5 papers · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers

Papers 16

  1. The impact of FDG-PET/CT on the diagnostic pathway of surgically treated pancreatic ductal adenocarcinoma: the Surg-Panc-UK study. Co-author DOI 10.1016/j.hpb.2025.05.003↗
  2. Impact of social deprivation upon the preoperative pathway and early surgical outcomes after pancreatoduodenectomy for PDAC and non-PDAC periampullary cancer i… Co-author DOI 10.1016/j.hpb.2025.07.007↗
  3. An update on pancreatic cancer imaging, staging, and use of the PACT-UK radiology template pre- and post-neoadjuvant treatment. Co-author DOI 10.1093/bjr/tqae217↗
  4. Calcium channel blockers are associated with improved survival in pancreatic cancer patients undergoing neoadjuvant chemotherapy and resection. Co-author DOI 10.1016/j.hpb.2023.12.001↗
  5. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study. Co-author DOI 10.1038/s41416-023-02220-2↗
  6. PACT-UK (PAncreatic Cancer reporting Template-UK): a cross-specialty multi-institutional consensus panel development of a standardised radiological reporting p… Co-author DOI 10.1136/bmjonc-2023-000055↗
  7. Surgical Management of Non-Metastatic Pancreatic Cancer in the United Kingdom: Results of a Nationwide Survey on Current Practice. Co-author DOI 10.3389/fonc.2021.791946↗
  8. Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer. First author DOI 10.1016/j.pan.2020.06.012↗
  9. The quality of pain management in pancreatic cancer: A prospective multi-center study. Co-author DOI 10.1016/j.pan.2020.08.017↗
  10. Neoadjuvant therapy in elderly patients receiving FOLFIRINOX or gemcitabine/nab-paclitaxel for borderline resectable or locally advanced pancreatic cancer is f… First author DOI 10.1016/j.suronc.2020.08.031↗
  11. Calcium channel blockers in pancreatic cancer: increased overall survival in a retrospective cohort study. Co-author DOI 10.1097/cad.0000000000000947↗
  12. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001689↗
  13. NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer. Co-author DOI 10.1002/jso.25209↗
  14. The role of pancreatic stellate cells in pancreatic cancer. Co-author DOI 10.1016/j.suronc.2015.05.002↗
  15. Arrested development and the great escape--the role of cellular senescence in pancreatic cancer. Co-author DOI 10.1016/j.biocel.2014.10.018↗
  16. Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer. Co-author DOI 10.1016/j.ejso.2014.08.480↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Samuel James Tingle · 3 shared papers, 2018–2024 · strength 0.53
  2. Raneem Albazaz · 2 shared papers, 2023–2025 · strength 0.52
  3. Ganesh Radhakrishna · 2 shared papers, 2023–2025 · strength 0.52
  4. Juan W. Valle · 2 shared papers, 2023–2025 · strength 0.52
  5. Samir Pathak · 2 shared papers, 2021–2025 · strength 0.41
  6. Nigel Balfour Jamieson · 2 shared papers, 2021–2025 · strength 0.41
  7. Siobhan C. McKay · 2 shared papers, 2021–2025 · strength 0.41
  8. Keith John Roberts · 2 shared papers, 2021–2025 · strength 0.41
  9. Steven Alan White · 3 shared papers, 2014–2020 · strength 0.34
  10. Carmelo Corallo · 1 shared paper, 2025 · strength 0.28
  11. Jenifer Barrie · 1 shared paper, 2025 · strength 0.28
  12. Thomas Thorne · 1 shared paper, 2025 · strength 0.28
  13. Marko Damm · 3 shared papers, 2020 · strength 0.27
  14. Maximilian Weniger · 3 shared papers, 2020 · strength 0.27
  15. Stephan Schorn · 3 shared papers, 2020 · strength 0.27
  16. Jonas Rosendahl · 3 shared papers, 2020 · strength 0.27
  17. Guralp Onur Ceyhan · 3 shared papers, 2020 · strength 0.27
  18. Richard Charnley · 3 shared papers, 2020 · strength 0.27
  19. Jelena Mann · 3 shared papers, 2014–2020 · strength 0.26
  20. Zhi Ven Fong · 1 shared paper, 2024 · strength 0.26
  21. Motaz Qadan · 1 shared paper, 2024 · strength 0.26
  22. Steve A. White · 2 shared papers, 2015–2020 · strength 0.19
  23. Patrick Michl · 2 shared papers, 2020 · strength 0.19
  24. Derek Manas · 2 shared papers, 2014–2020 · strength 0.16
  25. Giuseppe Malleo · 2 shared papers, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.